Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy A Schafer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 5, 2011
Formulary management of the protease inhibitors boceprevir and telaprevir for chronic hepatitis C virusAlexandra Tungol, Kellie Rademacher, Jeremy A Schafer
Journal of Managed Care Pharmacy : JMCP|November 12, 2010
Price increases and new drugs drive increased expenditures for multiple sclerosisJeremy A Schafer, Brent W Gunderson, Patrick P Gleason
Cardiovascular Therapeutics|January 16, 2010
Dronedarone: current evidence and future questionsJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP|May 9, 2009
Critical review of prasugrel for formulary decision makersJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP|July 20, 2010
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasisJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
The Journal of Antimicrobial Chemotherapy|June 1, 2006
Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM)Jeremy A Schafer, Laurie B Hovde, John C Rotschafer
Pharmacotherapy|March 27, 2007
Penicillin allergy skin testing: what do we do now?Jeremy A Schafer, Noe Mateo, Garry L Parlier, et al.
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Telithromycin: the perils of hasty adoption and persistence of off-label prescribingPatrick P Gleason, Carol Walters, Alan H Heaton, et al.
Journal of Managed Care Pharmacy : JMCP|August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning eventsCatherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Association of prescription abandonment with cost share for high-cost specialty pharmacy medicationsPatrick P Gleason, Catherine I Starner, Brent W Gunderson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Managed Care Pharmacy : JMCP|November 5, 2011
Formulary management of the protease inhibitors boceprevir and telaprevir for chronic hepatitis C virusAlexandra Tungol, Kellie Rademacher, Jeremy A Schafer
Journal of Managed Care Pharmacy : JMCP|November 12, 2010
Price increases and new drugs drive increased expenditures for multiple sclerosisJeremy A Schafer, Brent W Gunderson, Patrick P Gleason
Cardiovascular Therapeutics|January 16, 2010
Dronedarone: current evidence and future questionsJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP|May 9, 2009
Critical review of prasugrel for formulary decision makersJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP|July 20, 2010
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasisJeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
The Journal of Antimicrobial Chemotherapy|June 1, 2006
Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM)Jeremy A Schafer, Laurie B Hovde, John C Rotschafer
Pharmacotherapy|March 27, 2007
Penicillin allergy skin testing: what do we do now?Jeremy A Schafer, Noe Mateo, Garry L Parlier, et al.
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Telithromycin: the perils of hasty adoption and persistence of off-label prescribingPatrick P Gleason, Carol Walters, Alan H Heaton, et al.
Journal of Managed Care Pharmacy : JMCP|August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning eventsCatherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Association of prescription abandonment with cost share for high-cost specialty pharmacy medicationsPatrick P Gleason, Catherine I Starner, Brent W Gunderson, et al.
Pageof 2